South & Central America Opioids Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Product (Immediate Release Short Acting Opioid and Extended Release Long Acting Opioid), Application (Pain Management, Anesthesia, Diarrhea Suppression, Cough Suppression, De-Addiction, and Others), Route of Administration (Oral, Injectable, and Transdermal Patch), and Distribution Channel (Hospital Pharmacies and Retail Pharmacies)

No. of Pages: 74    |    Report Code: BMIRE00031031    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Opioids Market

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Opioids Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Surging Chronic Pain Incidence

4.1.2 Increasing Geriatric Population

4.2 Market Restraints

4.2.1 Increasing Drug Abuse

4.3 Market Opportunities

4.3.1 Strategic Initiatives by Market Players

4.4 Impact of Drivers and Restraints:

5. Opioids Market - South & Central America Analysis

5.1 South & Central America Opioids Market Revenue (US$ Million), 2020-2030

5.2 South & Central America Opioids Market Forecast Analysis

6. South & Central America Opioids Market Analysis - by Product

6.1 Immediate Release Short Acting Opioid

6.1.1 Overview

6.1.2 Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.1.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

6.2 Extended Release Long-Acting Opioid

6.2.1 Overview

6.2.2 Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.2.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. South & Central America Opioids Market Analysis - by Application

7.1 Pain Management

7.1.1 Overview

7.1.2 Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Anesthesia

7.2.1 Overview

7.2.2 Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Diarrhea Suppression

7.3.1 Overview

7.3.2 Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Cough Suppression

7.4.1 Overview

7.4.2 Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.5 De-Addiction

7.5.1 Overview

7.5.2 De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Opioids Market Analysis - by Route of Administration

8.1 Oral

8.1.1 Overview

8.1.2 Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Injectable

8.2.1 Overview

8.2.2 Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Transdermal Patch

8.3.1 Overview

8.3.2 Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Opioids Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview

9.1.2 Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview

9.2.2 Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Opioids Market - Country Analysis

10.1 South & Central America

10.1.1 South & Central America Opioids Market, by Key Countries - Revenue (2022) (US$ Million)

10.1.2 South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

10.1.2.1 South & Central America: Opioids Market - Revenue and Forecast Analysis - by Country

10.1.2.2 Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.2.2.1 Brazil: South & Central America Opioids Market Breakdown, by Product

10.1.2.2.2 Brazil: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.2.2.3 Brazil: South & Central America Opioids Market Breakdown, by Extended Release Long Acting Opioid

10.1.2.2.4 Brazil: South & Central America Opioids Market Breakdown, by Application

10.1.2.2.5 Brazil: South & Central America Opioids Market Breakdown, by Route of Administration

10.1.2.2.6 Brazil: South & Central America Opioids Market Breakdown, by Distribution Channel

10.1.2.3 Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.2.3.1 Argentina: South & Central America Opioids Market Breakdown, by Product

10.1.2.3.2 Argentina: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.2.3.3 Argentina: South & Central America Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.2.3.4 Argentina: South & Central America Opioids Market Breakdown, by Application

10.1.2.3.5 Argentina: South & Central America Opioids Market Breakdown, by Route of Administration

10.1.2.3.6 Argentina: South & Central America Opioids Market Breakdown, by Distribution Channel

10.1.2.4 Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.2.4.1 Rest of South & Central America: Opioids Market Breakdown, by Product

10.1.2.4.2 Rest of South & Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.2.4.3 Rest of South & Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid

10.1.2.4.4 Rest of South & Central America: Opioids Market Breakdown, by Application

10.1.2.4.5 Rest of South & Central America: Opioids Market Breakdown, by Route of Administration

10.1.2.4.6 Rest of South & Central America: Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Opioids Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Endo International plc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Mallinckrodt Plc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Neuraxpharm Pharmaceuticals SL

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Rusan Pharma Ltd

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Teva Pharmaceutical Industries Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

 

 

 

List of Tables

Table 1. South & Central America Opioids Market Segmentation

Table 2. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 4. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 5. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 6. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 7. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 8. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 9. South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country

Table 10. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 11. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 12. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid

Table 13. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 14. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 15. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 16. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 17. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 18. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 19. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 20. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 21. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 22. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 23. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 24. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid

Table 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 26. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 27. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 28. Recent Organic Growth Strategies in Opioids Market

Table 29. Recent Inorganic Growth Strategies in the Opioids Market

Table 30. Glossary of Terms, Opioids Market

 

List of Figures

Figure 1. South & Central America Opioids Market Segmentation, by Country

Figure 2. South & Central America Opioids Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. South & Central America Opioids Market Revenue (US$ Million), 2020-2030

Figure 5. South & Central America Opioids Market Share (%) - by Product (2022 and 2030)

Figure 6. Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. South & Central America Opioids Market Share (%) - by Application (2022 and 2030)

Figure 9. Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. South & Central America Opioids Market Share (%) - by Route of Administration (2022 and 2030)

Figure 16. Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. South & Central America Opioids Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 20. Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 23. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Growth Strategies in Opioids Market

 

 

The List of Companies - South & Central America Opioids Market

  1. Endo International plc
  2. Mallinckrodt Plc
  3. Neuraxpharm Pharmaceuticals SL
  4. Rusan Pharma Ltd
  5. Teva Pharmaceutical Industries Ltd